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ABSTRACT  
Study Design: Prospective Cohort Study 
Objective: The aim of this paper is to compare the mid- to long-term patient-reported 
outcome measures (PROMs) between single-level total disc arthroplasty (TDA), multi-level 
TDA, and hybrid constructs (combination of TDA and anterior lumbar interbody fusion 
(ALIF) across multiple levels) for symptomatic degenerative disc disease (DDD). 
Summary of Background Data:  The treatment of single-level DDD is well documented 
using TDA. However, there  is still a paucity of published evidence regarding long-term 
outcomes on multi-level TDA and hybrid constructs for the treatment of multi-level DDD, as 
well as lack of long-term comparisons regarding treatment of single-level DDD and multi-
level DDD. 
Methods: 950 patients underwent surgery for single-level or multi-level DDD between July 
1998 and February 2012 with single-level TDA (n = 211), multi-level TDA (n = 122) or 
hybrid construct (n = 617). Visual Analog Score for the back (VAS-B) and leg (VAS-L) were 
recorded, along with the Oswestry Disability Index (ODI) and Roland Morris Disability 
Questionnaire (RMDQ).  
Results:  All PROMs in all groups showed statistically and clinically significant 
improvements (p < 0.005) in pain and function that is well above the corresponding minimum 
clinically important difference (MCID) and exceeds literature thresholds for substantial 
clinical benefit (SCB). Unadjusted analyses show that there were no statistically significant 
differences in the change scores between the surgery groups for VAS back and leg pain, and 
RMDQ up to 8 years follow-up. Adjusted analyses showed the ODI improvement score for 
the single group was 2.2 points better (95%CI: 0.6, 3.9, p=0.009) than in the hybrid group. 
The RMDQ change score was better in the hybrid group than in the multi-level group by 1.1 
points (95%CI: 0.4, 1.9, p=0.003) at 6 months and a further 0.4 point at 2 years (95%CI: 0.1, 
0.8, p=0.011). 
Conclusions: In the setting of meticulous pre-operative evaluation in establishing a precision 
diagnosis, clinically and statistically equivalent results can be achieved when treating 
symptomatic DDD through single-level TDA, multi-level TDA, and hybrid constructs. These 
results are sustained at mid- to long-term follow-up. 
Key Words: artificial disc, back pain, degenerative disc disease, motion preservation, total 
disc replacement, arthroplasty, long-term results, lumbar spine, comparison. 
Level of Evidence:  3 
  
MINI ABSTRACT 
Patients (n=950) underwent surgery for single-level or multi-level degenerative disc disease 
with single-level total disc arthroplasty (TDA), multi-level TDA or a hybrid construct. 
Clinically and statistically significant results were achieved with each treatment method. 





The prevalence of low back pain  worldwide ranges from 1.4 to 20% with a lifetime 
incidence ranging from 50 to 80%.1,2 Low back pain caused by discogenic pain from lumbar 
degenerative disc disease (DDD) is a specific diagnosis that can be treated operatively or 
non-operatively.3 The diagnosis is made from a combination of a clinical history, physical 
examination, radiological investigations, such as magnetic resonance imaging (MRI), and 
discriminating provocative discography with post discography computed tomography (CT) 
scans.4,5 Other authors have also found electrophysiological studies, 6 MR spectroscopy7 and 
SPECT scanning8 adjunctive in supporting a diagnosis. DDD can be present at single or 
multiple levels, and a variety of reconstructive options are available. 
Options to treat single-level DDD operatively include total disc arthroplasty (TDA) or 
anterior lumbar interbody fusion (ALIF). TDA acts as a dynamic motion segment stabilizer, 
and has been shown to reduce back pain, improve functional outcomes, and reduce clinical 
and radiological adjacent segment pathology (CASP/RASP).9  ALIF acts as a static motion 
segment stabilizer with similar improvement in clinical outcomes.10,11 The pathogenesis of 
CASP/RASP remains unknown but is probably multifactorial. Changes may be related to the 
biomechanical effects after ALIF that alter the biomechanics at the adjacent levels, leading to 
increased intradiscal pressure and, therefore, increased load and mobility resulting in 
accelerated degeneration. 12,13  
Although there is ample evidence to suggest single-level TDA is efficacious compared to 
arthrodesis, there is less long-term evidence to support the use of multi-level TDA in multi-
level DDD.14–17 Some authors found no significant difference between single-level TDA and 
multi-level TDA but lacked long-term data.18 Another surgical option is to treat multi-level 
DDD with multi-level ALIF, although this can result in higher rates of CASP/RASP and 
increased non-union rates.19 An alternative to multi-level TDA and multi-level ALIF is the 
hybrid procedure, which combines the motion preservation of TDA and stability from 
ALIF.20,21 Other surgical preferences for treating DDD include transforaminal or posterior 
lumbar interbody fusion, and lateral based techniques. There is considerable evidence on the 
benefits of TDA22,10 ALIF23,24 and hybrid9,25,21,26 constructs in treating symptomatic DDD 
with comparison studies showing similar clinical outcomes.27,28,11,17,29,24 However, there are 
few long-term studies comparing these procedures with each other. 
Given the lack of long-term data and comparator studies, the aim of this prospective cohort 
study was to compare the mid- to long-term patient-reported outcome measures (PROMs) 
between single-level TDA, multi-level TDA, and hybrid constructs for the indication of 
symptomatic DDD. It is hypothesized that patients who are carefully selected and matched 
with the appropriate treatment technology will achieve similar clinical outcomes over the 
mid- to long-term.  The clinical decision to offer multilevel LTDA or a hybrid procedure was 
based on quality of bone, the number of levels, facet arthropathy, the location and type of 
radiculopathy, and the relationship of the pelvic incidence to actual and theoretical lumbar 
lordosis. In addition, prior to 2006 in Australia LTDA had informal funding arrangements 
and could be performed at multiple levels using ALIF reimbursement Medicare item 
numbers. Subsequently, an application for a TDR specific Medicare item number was made 
and only single level TDA was supported by Medicare.  Currently  multiple level TDA are 
only available on approval by third party payers or to self-funded patients.  Therefore, hybrid 
procedures became the main treatment option for those patients with symptomatic multi-level 
DDD. This precipitated the emerging concept of level-specific matching the technology with 
the pathology. 
MATERIALS AND METHODS  
This was a prospective cohort study of 950 patients who were operated for single-level or 
multi-level DDD between July 1998 and February 2012 with single-level TDA (n = 211), 
multi-level TDA (n = 122) or a hybrid construct (n = 617). This study was approved by the 
Bond University Human Research Ethics Committee (0000015881).  
All participants suffered chronic low back pain (≥12 months) that was unresponsive to active 
nonoperative treatment, including physical therapy. A diagnosis of single-level or multi-level 
discogenic low back pain, with or without radicular pain, was established through clinical 
history, examination, and diagnostic imaging, which included a combination of standing 
lumbar radiographs, MRI, and provocative discography, with post-discography fine cut CT 
scan. Because of the high sensitivity and specificity of MRI, it remains an excellent tool for 
assessing disc morphology, but should be used in conjunction with discography when 
planning surgical treatment.30 Discography was used in all patients. The general principles 
outlined by the International Association for the Study of Pain (IASP)31 were followed when 
utilizing discography as an investigative tool. Patients whose discographic results that were 
non-concordant were not offered surgery. Electrophysiological studies (needle 
electromyography and nerve conduction studies) were performed to confirm the presence or 
absence of radiculopathy, myopathies, peripheral neuropathies, and degenerative neurological 
conditions. In patients with complex vascular anatomy, a CT angiogram was obtained. 
Surgery was offered to patients with a precision diagnosis of discogenic pain who had 
exhausted nonoperative modalities, and where their condition was having significant impact 
upon their social, recreational and employment activities.  
Surgery was performed via a midline rectus split with a left- or right-sided retroperitoneal 
approach. Different types of prosthesis were used through the study for each group. Levels 
undergoing ALIF in the hybrid construct group received PEEK cages, either with integrated 
cage and screw systems or with a cage and plate with screws combination. Posterior 
instrumentation was not used. Recombinant human bone morphogenic protein–2 (rhBMP-2), 
INFUSE Bone Graft (Medtronic Inc, Memphis, TN) was used in all ALIFs. There was no 
evidence of pseudoarthrosis. At 6 months post-op, this was verified by flexion/extension 
films and a fine cut 3-dimensional reconstructed computed tomography scan. The variation in 
specific prostheses was because of availability, design evolution, and surgeon preference at 
the time of surgery. 
Contraindications to surgery included active infection, tumours, significant scoliosis (>20°), 
severe atherosclerosis and pregnancy. Obesity and involvement in worker’s compensation or 
other litigation were regarded as relative contraindications.  
PROMs were obtained preoperatively, then postoperatively at 3, 6, and 12 months, and 
annually thereafter. Collected PROMs included Visual Analog Score for back (VAS-B) and 
leg (VAS-L) were recorded on a 0-100 scale, Oswestry Disability Index (ODI), and Roland 
Morris Disability Questionnaire (RMDQ). Patient satisfaction was assessed with a four-scale 
written questionnaire (excellent, good, satisfactory, and poor). Radiographic assessment was 
performed to confirm movement, alignment, and lack of complication of the construct e.g., 
subsidence, heterotopic ossification, and adjacent segment degeneration. Plain radiographs, 
including erect flexion-extension views, were obtained at 3, 6, and 12 months. Cases that 
received ALIF, a fine-cut CT scan was obtained at 6 months to verify radiographic union. 
Statistical Analyses 
Data was analyzed by an independent university affiliated research team with R statistical 
softwareÔ version 3.5.0. Each cohort was compared for VAS-B, VAS-L,32 ODI33 and RMDQ 
disability34,35 prior to surgery, at baseline and post-operatively at 3 months, 6 months, 12 
months and yearly thereafter. Change-from-baseline scores for each of these four measures 
were used as main outcomes. Baseline characteristics were compared using chi-square tests 
for categorical variables and one-way ANOVA or Kruskal-Wallis tests depending on the 
distribution of the continuous variables. The change in scores for the surgery groups were 
compared using one-way ANOVA or Kruskal-Wallis tests at each time-point, with 
Bonferroni method used to correct for multiple comparisons. Adjusted analyses were carried 
out using linear mixed models to assess the effect of surgery type on the outcomes, whilst 
controlling for baseline score and age, at specific timepoints: 6 months, 2 years, 4 years, and 
8 years post-surgery. Interactions between time and surgery type were assessed but were not 
used in the final models as they were not significant. Significance for the adjusted analyses 
was set at 0.0125 a priori.  
Graphical representations of median changes in VAS and mean differences in ODI and 
RMDQ were plotted along with 95% confidence interval (CI) and the corresponding 
minimum clinically important difference (MCID) and substantial clinical benefit (SCB) for 
each outcome.36,37  
RESULTS 
A total of 950 patients underwent one of three procedures: hybrid (n=617), single-level TDA 
(n=211) or multi-level TDA (n=122). The median follow-up times, with interquartile ranges 
(IQR), were 3 years (IQR 2-5) for hybrid, 8 years (IQR 6-11) for single, and 9 years (IQR 6-
10) for multi-level. In the single-level cohort, 13.2% of patients were lost to follow-up at an 
average of 58.3 months post-operatively. The majority of these were lost despite 77% rating 
their satisfaction as good to excellent at the last point of follow-up. In the multi-level TDA, 
19.67% were lost to follow-up at an average of 79.7 months post-operatively. The majority 
were lost to follow-up despite 58% rating their satisfaction as good to excellent. In the hybrid 
cohort, 25% of patients were lost to follow-up, the majority of which were lost at the 12- to 
24-month stage. The majority were lost to follow-up despite 82.8% rating their satisfaction as 
good to excellent at final follow-up. The demographic and preoperative patient characteristics 
are presented in Table 1. All groups were similar for surgical indications (DDD) and surgical 
approach. Demographics were comparable, except for age where the hybrid group had 
significantly older patients (p<0.001). Baseline PROMs were comparable, except in the 
multi-level group where VAS-B (median 80, IQR 65.5-91.0) was statistically higher than the 
single-level group (75.0, 55.0-89.0, p=0.03) and the hybrid group (74.0, 60.0-86.0, p=0.02). 
The ODI baseline score was also higher in the multi-level group (median 48.0, IQR 34.5-
60.0) than the hybrid group (44.0, 34.0-54.0, p=0.04). The revision/reoperation rate were for 
single level 2.8%, multiple level 5.4%, and hybrid 3.7%. The index level and adjacent level 
revision and reoperation rate were equally divided. All index levels were at the TDA level. 
There were no reoperations for pseudoarthrosis and all fusions were standalone constructs. 
The indications for index level revision spine surgery of the total disc replacements included 
facet arthropathy, subsidence, and migration of the implant. Most patients underwent RSS by 
a posterior spinal fusion/decompression for FA and/or neural compression. The median time 
to revision was 35 months (IQR 9-51), suggesting an element of kinematic mismatch 
resulting in facet degeneration and time for the pathology to develop and become 
symptomatic. Most (85%) were at L5-S1 with unconstrained prosthesis. 
Figures 1-4 are graphical representations of the change in scores for VAS-B and VAS-L and 
the ODI and RMDQ outcome measures over time. The relevant MCID and SCB for each 
outcome measure is included. All groups showed a statistical improvement from base line in 
pain and function that was well above the corresponding MCID. Unadjusted analyses show 
that there were no statistically significant differences in the change scores between the 
surgery groups for VAS-B, VAS-L and RMDQ. The ODI improvement in the single-level 
group compared with the hybrid group reached statistical significance with an average of 7.2 
points at 3 months, 3 years, and 4 years post-surgery (p<0.001). However, these differences 
were not clinically significant. 
Table 2 and Table 3 display the PROMs summary statistics for the adjusted analyses using 
linear mixed models to assess the effect of surgery type on the outcomes, whilst controlling 
for baseline score and age. These results show that, after adjusting for baseline score and age, 
there were no significant differences in change scores between surgery types for VAS-B and 
VAS-L pain. The ODI improvement for the single-level group was 7.2 points better (95%CI: 
0.6, 3.9, p=0.009) than in the hybrid group. The RMDQ change was better in the hybrid 
group than in the multi-level group by 1.1 points (95% CI: 0.4, 1.9, p=0.003) at 6 months and 
a further 0.4 points at 2 years (95%CI: 0.1, 0.8, p=0.011). 
Figure 5 compares patient satisfaction between the three surgical groups, with consistently 
high rates of good to excellent patient satisfaction reported and sustained over time. 
Table 4 shows the mean percentage of surgery patients who achieved MCID and SCB in the 
first 8 years post-surgery. 
DISCUSSION 
The aim of this prospective cohort study was to compare the mid- to long-term PROMs 
between single-level TDA, multi-level TDA, and hybrid constructs for the treatment of 
symptomatic DDD when appropriate methods of diagnosis, patient selection and technique 
are followed. Clinically relevant and statistically significant improvements in all PROMs 
were achieved from baseline measures at all time points post-operatively in all three groups. 
Comparing the groups showed no statistically significant differences in the changes in score 
between the groups for VAS-B and VAS-L through unadjusted analyses and linear mixed 
modelling. However, statistically significant difference in improvements in ODI were found 
in the single-level group compared to the hybrid group in the early post-operative period (≤ 4 
years post-op). Past this time-point, the data clustered together showing similar 
improvements in outcomes independent of group or whether the diagnosis was single- or 
multi-level DDD. The results of this cohort study demonstrate that single-level TDA, multi-
level TDA, and hybrid constructs are all effective in treating symptomatic DDD, with no 
clinical difference in PROMs between the groups up to 8 years follow-up. 
All three groups had similar demographics, except for age in the hybrid group. The hybrid 
group was significantly older (p<0.001). This can be explained by the higher incidence of 
facet joint osteoarthritis in older patients (a contraindicated for TDA) and age related 
degenerative processes that leads to multi-level pathology.20 The premise behind the hybrid 
construct is to address multi-level DDD by matching pathology with technology, whereby 
levels with advanced degeneration, facet arthropathy, or segment instability are treated with 
ALIF while TDA is reserved for levels without significant segmental instability or facet 
arthropathy.38 Despite the difference in age between the hybrid group and single- and multi-
level TDA, the clinical outcomes for VAS-B, VAS-L, and RMDQ were similar. 
Long-term studies for single-level TDA show favorable outcomes compared to fusion 
surgery, with comparable outcomes for back and leg pain and reduction of CASP/RASP.39,40 
However, with multi-level DDD, there were concerns regarding rates of failure in multi-level 
TDA because of the difficulty in positioning and balancing of multiple TDAs, particularly in 
the setting of unconstrained and semi-constrained prostheses, as well as concerns regarding 
facet arthritis and segmental instability.41,42,43 Other considerations for multi-level TDA 
include spinopelvic parameters, operative level, bone density, and presence of other 
comorbidities.44 Zigler et al. compared single-level TDA to two-level TDA and found that 
two-level TDA is just as effective as one-level in treating symptomatic DDD in appropriately 
selected patients.45 Schätz et al. also found adequate initial safety and effectiveness at the two 
year time point for both single and multi-level TDA but cautioned that a larger sample size 
and extended follow-up were necessary.28 Yue et al. presented 5 year data comparing single-
level and two-level arthroplasty.46 Similarly, they did not find statistical differences in all 
clinical and radiological outcomes, but also recommended longer follow-up to confirm.  
The findings previously reported are consistent with the results from our study, where both 
the single- and multi-level groups showed statistically significant improvements in all 
PROMs, with no statistically significant difference between the groups up to 8 years post-
operatively. This study highlights the sustained improvements and minimal difference in mid- 
to long-term data on the efficacy of single- and multi-level TDA, when matching the 
technology to pathology. The authors recognize the importance of coronal and sagittal 
balance, as well as use of constrained and unconstrained TDA, which is highlighted in a 
previous study.44 
Only the single-level TDA group showed significantly better ODI improvement over the 
hybrid group at 3 months, 3 years, and 4 years post-surgery (p<0.001). The difference was 
not clinically significant and, after 4 years post-surgery, the difference became insignificant. 
The authors believe this relates to the greater complexity in pathology and surgery in the 
hybrid group compared to the single-level group. The hybrid group were older and the 
surgery involves 2 or more levels, which results in longer recovery time. However, given the 
PROMs eventually clustered together over time, the authors suggest that clinical 
improvements continue as the patient gains strength and confidence, until a sustained steady 
state is reached. To our knowledge, this is the first cohort study comparing the mid- to long-
term PROMs of single-level TDA with hybrid constructs. 
There are a limited number of published comparative studies that compare hybrid constructs 
with either multi-level TDA or multi-level ALIF.20,21 Andrieu et al. found no statistical 
difference in pain relief (-3.9 points versus -3.5 points for VAS) or reduction in ODI (-29.5% 
versus -27.0%) between two-level TDA and two-level hybrid constructs, respectively after 2 
years of follow-up.20 Similarly, in this study, the PROMs comparing the hybrid group and 
multi-level TDA were not statistically significant. However, after a linear mixed model was 
applied, the RMDQ in the hybrid group was better than the multi-level TDA group at 6 
months by 1.1 points (95%CI: 0.4, 1.9, p=0.003) and 1.5 point at 2 years (95%CI: 0.1, 0.8, 
p=0.011). The authors cannot account for the initial difference in the early post-operative 
period in RMDQ but suggest this may relate to improved sagittal and coronal correction 
made possible with the ALIF component of hybrid procedures. Use of hyper lordotic ALIF 
cages enables greater sagittal and coronal realignment and disc height restoration than TDA 
prostheses alone. 
Chen et al. compared the hybrid construct against multi-level ALIF and found the hybrid 
construct was a valid and viable alternative, with at least equal if not better clinical outcomes 
in terms of survivorship, back pain, and disability scores.21 This present study similarly 
demonstrates equivalent improvement in PROMs in all groups. 
Limitations of this study include all cases being performed by a single surgeon at a single 
institution, which affects the generalizability of the results.47,48 Another limitation is the lack 
of a control group in the context of an RCT protocol and is inherent in observational studies. 
Finally, there is the question of the ideal PROMs to use in a spinal surgery study. Some 
PROMs scoring systems lack sensitivity in measurement of subtleties of function to 
accurately define utility. Furthermore, PROMs do not evaluate important economic 
outcomes, which are increasingly being recognized as relevant to healthcare payers and the 
sustainability of a treatment. A systematic review by Ishaque et al. suggests PROMs are an 
effective intervention in evidence based medicine, through improving communication and 
decision-making process about the potential benefits of surgery. 49  Finally, there is also the 
issue of reporting bias inherent in PROMs. Despite these limitations, the value of PROMs in 
comparing the results of treatment modalities is well established.   
CONCLUSION 
This study shows clinically and statistically significant reduction in back and leg pain, as well 
as self-rated disability outcomes in the single-level TDA, multi-level TDA, and hybrid 
construct groups, which was sustained for at least 8 years. There was no clinically significant 
difference in PROMs between all the groups up to 8 years post-operatively. This suggests 
that single-level TDA, multi-level TDA, and hybrid constructs are all viable and suitable 
options for patients suffering chronic back and leg pain, provided a precision diagnosis has 
been made and it is matched by an appropriate surgical treatment. To our knowledge, this 
represents the largest cohort and longest follow-up comparing PROMs of single-, multi-level 
TDA, and hybrid constructs in the literature. 
Key Points:  
 Single-level TDA, multi-level TDA and hybrid constructs are viable options for 
treating symptomatic DDD. 
 Statistically and clinically significant benefits were achieved with all surgery groups, 
which were clustered and sustained up to 8 years post-surgery. 
 There is no clinically significant difference in PROMs between single-level TDA, 
multi-level TDA and hybrid constructs. 
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Figure 1. Median improvement in VAS-B pain score after surgery was statistically (p<0.001) 
and clinically significant (>MCID 12, >SCB 25) for each of three surgery procedures. There 
were no statistically significant differences between surgery types. 
VAS-B indicates Visual Analogue Scale Back; SCB, substantial clinical benefit; MCID, 
Minimum Clinically Important Difference; CI, Confidence Interval. 
 
Figure 2. Median improvement in VAS-L pain score after surgery was statistically (p<0.001) 
and clinically significant (>MCID 16, >SCB 25) for each of three surgery procedures. There 
were no statistically significant differences between surgery types. 
VAS-L indicates Visual Analogue Scale Leg; SCB, substantial clinical benefit; MCID, 
Minimum Clinically Important Difference; CI, Confidence Interval. 
 
Figure 3. Mean improvement in ODI score after surgery was statistically (p<0.001) and 
clinically significant (>MCID 10, >SCB 18.8) for each of three surgery procedures. The 
single-level procedure was statistically better than the hybrid procedure by 7.2 points at 3 
months, 3 and 4 years (p<0.001). 
ODI indicates Oswestry Disability Index; SCB, substantial clinical benefit; MCID, Minimum 
Clinically Important Difference; CI, Confidence Interval. 
 
Figure 4. Mean improvement in RMDQ disability score after surgery was statistically 
(p<0.001) and clinically significant (>MCID 5) for each of three surgery procedures. There 
were no statistically significant differences between surgery types. 
RMDQ indicates Roland Morris Disability Questionnaire; MCID, Minimum Clinically 
Important Difference; CI, Confidence Interval. 
 




Table 1. Characteristics of surgery patients (N=950) 
Characteristic 
Hybrid procedure 
N = 617 
Single-level 
N = 211 
 Multi-level 
N = 122 
Follow-up (years), median (IQR) 
                                        Minimum 







 9 (6–10) 
2  
10  
Gender, n (%) 
                                              Female 


















Levels operated, n (%) 2 level – 500 (81.0) 
3 level – 116 (18.8) 
4 level – 1 (0.2) 
1 level – 211 
(100) 
 2 level - 120 
(98.4) 
3 level – 2 (1.6) 
Baseline pain score, median (IQR) 
                                    VAS-Bpain2 





 80.0 (65.5–91.0) 
54.5 (19.3–81.0) 
Baseline disability score, median 
(IQR) 
                                               ODI3 










IQR indicates  Interquartile range; SD, standard deviation; VAS-B, Visual Analogue Scale Back; VAS-L, Visual 
Analogue Scale Leg; ODI, Oswestry Disability Index; RMDQ, Roland-Morris Disability Questionnaire. 
1 Age at time of surgery was significantly different between the hybrid group and each of the other  
two groups (p<0.001). 
2 Baseline VAS-B pain in the multi-level group was higher compared with the hybrid (p=0.02) and the single-
level (p=0.03) groups. 
3 Baseline ODI was higher in the multi-level group compared with the hybrid group (p=0.04). 
Table 2. Results of the linear mixed regression modelling of pain change scores over 8 
years 
Parameter Beta Coefficient  95% CI p-value 
VAS-B pain 
Intercept  56.5 (54.8, 58.2) <0.001* 
Baseline score (centred on 75) 0.8 (0.80, 0.90) <0.001* 
Age (centred on 45) -0.1 (-0.21, 0.01)   0.08 
Year 2 0.5 (-1.1, 2.1)   0.56 
Year 4 -3.1 (-5.0, -1.1)   0.002* 
Year 8 -7.4 (-11.0, -3.8) <0.001* 
Single-level 3.2 (0.4, 6.1)   0.03 
Multi-level -0.8 (-4.6, 3.0)   0.69 
VAS-L pain 
Intercept  42.6 (41.0, 44.1) <0.001* 
Baseline score (centred on 54) 0.9 (0.86, 0.93) <0.001* 
Age (centred on 45) -0.2 (-0.3, -0.1) <0.001* 
Year 2 0.6 (-1.0, 2.2)   0.45 
Year 4 -0.3 (-2.1, 1.5)   0.71 
Year 8 -1.4 (-4.3, 1.4)   0.32 
Single-level -0.1 (-2.7, 2.4)   0.91 
Multi-level -2.0 (-5.6, 1.6)   0.28 
* Statistically significant p<0.0125. 
The intercept coefficient represents the mean improvement at 6 months for  
patients in the hybrid group, with baseline pain score (VAS-B: 75; VAS-L: 54) and 
age 45. A negative coefficient signifies a decrease in improvement. 




Table 3. Results of the linear mixed regression modelling of disability change scores 
over 8 years 
Parameter Beta Coefficient  95% CI p-value 
ODI 
Intercept  31.3 (30.2, 32.3) <0.001* 
Baseline score (centred on 44) 0.8 (0.75, 0.84) <0.001* 
Age (centred on 45) -0.2 (-0.23, -0.16) <0.001* 
Year 2 0.9 (-0.1, 1.8)   0.07 
Year 4 -0.1 (-1.3, 1.0)   0.80 
Year 8 -1.6 (-3.5, 0.4)   0.12 
Single-level 2.2 (0.6, 3.9)   0.009* 
Multi-level -2.6 (-4.7, -0.5)   0.02 
RMDQ 
Intercept  12.6 (12.3, 13.0) <0.001* 
Baseline score (centred on 16) 0.9 (0.81, 0.90) <0.001* 
Age (centred on 45) -0.1 (-0.07, -0.03) <0.001* 
Year 2 0.4 (0.1, 0.8)   0.011* 
Year 4 0.2 (-0.2, 0.6)   0.31 
Year 8 0.1 (-0.5, 0.7)   0.82 
Single-level 0.6 (0.1, 1.2)   0.03 
Multi-level -1.1 (-1.9, -0.4)   0.003* 
* Statistically significant p<0.0125. 
The intercept coefficient represents the mean improvement at 6 months for  
patients in the hybrid group, with baseline disability score (ODI: 44; RMDQ: 16)  
and age 45. A negative coefficient signifies a decrease in improvement.  
ODI indicates Oswestry Disability Index; RMDQ, Roland Morris Disability Questionnaire; 
CI, Confidence Interval. 
 
 
Table 4. the mean percentage of surgery patients who achieved MCID and SCB in the 
first 8 years post-surgery 
 
VAS-B VAS-L ODI RMDQ 
% MCID % SCB % MCID % SCB % MCID % SCB % MCID 
Hybrid 89.2 80.0 66.5 59.7 86.2 73.0 86.6 
Single 85.5 75.4 70.6 64.3 90.3 79.0 89.2 
Multiple 92.0 82.7 65.5 58.8 86.9 73.1 88.2 
VAS-B indicates Visual Analogue Scale Back; VAS-L, Visual Analogue Scale Leg; ODI, 
Oswestry Disability Index; RMDQ, Roland Morris Disability Questionnaire; MCID, 
Minimum Clinically Important Difference; SCB, substantial clinical benefit 
 
 
